Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: a Randomized Controlled Trial

The impact of thiopurine de-escalation whilst on vedolizumab versus continuing thiopurine therapy in ulcerative colitis (UC) is unclear. We aimed to determine the effect of thiopurine withdrawal for patients with UC in remission on vedolizumab.

Source: Clinical Gastroenterology and Hepatology - May 8, 2024 Category: Gastroenterology Authors: Aviv Pudipeddi, Sudarshan Paramsothy, Viraj Kariyawasam, Ramesh Paramsothy, Simon Ghaly, Craig Haifer, Yoon-Kyo An, Jakob Begun, Susan J. Connor, Crispin Corte, Mark G. Ward, Peter De Cruz, Caroline Lan-San Fung, Diane Redmond, Webber Chan, Fadi Mourad, M Source Type: research